Eun Young Seong1,2, Yuanchao Zheng1, Wolfgang C Winkelmayer3, Maria E Montez-Rath1, Tara I Chang4. 1. Division of Nephrology, Stanford University School of Medicine, Palo Alto, California. 2. Division of Nephrology, Pusan National University School of Medicine, Pusan, South Korea; and. 3. Section of Nephrology, Baylor College of Medicine, Houston, Texas. 4. Division of Nephrology, Stanford University School of Medicine, Palo Alto, California; tichang@stanford.edu.
Abstract
BACKGROUND AND OBJECTIVES: Mesenteric ischemia is a rare but devastating condition caused by insufficient blood supply to meet the demands of intestinal metabolism. In patients with ESKD, it can be difficult to diagnose and has a >70% mortality rate. Patients on hemodialysis have a high prevalence of predisposing conditions for mesenteric ischemia, but the contribution of intradialytic hypotension, a potential modifiable risk factor, has not been well described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used data from the US Renal Data System to identify 626 patients on hemodialysis with a hospitalized mesenteric ischemia event (cases). We selected 2428 controls in up to a 1:4 ratio matched by age, sex, black race, incident dialysis year, diabetes mellitus, coronary artery disease, and peripheral artery disease. We used six different definitions of intradialytic hypotension on the basis of prior studies, and categorized patients as having had intradialytic hypotension if ≥30% of hemodialysis sessions in the 30 days before the event met the specified definition. RESULTS: The proportion of patients with intradialytic hypotension varied depending on its definition: from 19% to 92% of cases and 11% to 94% of controls. Cases had a higher adjusted odds (1.82; 95% confidence interval, 1.47 to 2.26) of having had intradialytic hypotension in the preceding 30 days than controls when using nadir-based intradialytic hypotension definitions such as nadir systolic BP <90 mm Hg. To examine a potential dose-response association of intradialytic hypotension with hospitalized mesenteric ischemia, we categorized patients by the proportion of hemodialysis sessions having intradialytic hypotension, defined using the Nadir90 definition (0%, 1%-9%, 10%-29%, 30%-49%, and ≥50%), and found a direct association of proportion of intradialytic hypotension with hospitalized mesenteric ischemia (P-trend<0.001). CONCLUSIONS: Patients with hospitalized mesenteric ischemia had significantly higher odds of having had intradialytic hypotension in the preceding 30 days than controls, as defined by nadir-based definitions.
BACKGROUND AND OBJECTIVES: Mesenteric ischemia is a rare but devastating condition caused by insufficient blood supply to meet the demands of intestinal metabolism. In patients with ESKD, it can be difficult to diagnose and has a >70% mortality rate. Patients on hemodialysis have a high prevalence of predisposing conditions for mesenteric ischemia, but the contribution of intradialytic hypotension, a potential modifiable risk factor, has not been well described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used data from the US Renal Data System to identify 626 patients on hemodialysis with a hospitalized mesenteric ischemia event (cases). We selected 2428 controls in up to a 1:4 ratio matched by age, sex, black race, incident dialysis year, diabetes mellitus, coronary artery disease, and peripheral artery disease. We used six different definitions of intradialytic hypotension on the basis of prior studies, and categorized patients as having had intradialytic hypotension if ≥30% of hemodialysis sessions in the 30 days before the event met the specified definition. RESULTS: The proportion of patients with intradialytic hypotension varied depending on its definition: from 19% to 92% of cases and 11% to 94% of controls. Cases had a higher adjusted odds (1.82; 95% confidence interval, 1.47 to 2.26) of having had intradialytic hypotension in the preceding 30 days than controls when using nadir-based intradialytic hypotension definitions such as nadir systolic BP <90 mm Hg. To examine a potential dose-response association of intradialytic hypotension with hospitalized mesenteric ischemia, we categorized patients by the proportion of hemodialysis sessions having intradialytic hypotension, defined using the Nadir90 definition (0%, 1%-9%, 10%-29%, 30%-49%, and ≥50%), and found a direct association of proportion of intradialytic hypotension with hospitalized mesenteric ischemia (P-trend<0.001). CONCLUSIONS:Patients with hospitalized mesenteric ischemia had significantly higher odds of having had intradialytic hypotension in the preceding 30 days than controls, as defined by nadir-based definitions.
Authors: Christopher W McIntyre; Laura E A Harrison; M Tarek Eldehni; Helen J Jefferies; Cheuk-Chun Szeto; Stephen G John; Mhairi K Sigrist; James O Burton; Daljit Hothi; Shvan Korsheed; Paul J Owen; Ka-Bik Lai; Philip K T Li Journal: Clin J Am Soc Nephrol Date: 2010-09-28 Impact factor: 8.237
Authors: Tara I Chang; David Shilane; Dhruv S Kazi; Maria E Montez-Rath; Mark A Hlatky; Wolfgang C Winkelmayer Journal: J Am Soc Nephrol Date: 2012-12 Impact factor: 10.121
Authors: Bergur V Stefánsson; Steven M Brunelli; Claudia Cabrera; David Rosenbaum; Emmanuel Anum; Karthik Ramakrishnan; Donna E Jensen; Nils-Olov Stålhammar Journal: Clin J Am Soc Nephrol Date: 2014-11-06 Impact factor: 8.237
Authors: Bruce E Sands; Mei-Sheng Duh; Clorinda Cali; Anuli Ajene; Rhonda L Bohn; David Miller; J Alexander Cole; Suzanne F Cook; Alexander M Walker Journal: Pharmacoepidemiol Drug Saf Date: 2006-01 Impact factor: 2.890
Authors: James O Burton; Helen J Jefferies; Nicholas M Selby; Christopher W McIntyre Journal: Clin J Am Soc Nephrol Date: 2009-04-08 Impact factor: 8.237
Authors: Indranil Dasgupta; G Neil Thomas; Joanne Clarke; Alice Sitch; James Martin; Brian Bieber; Manfred Hecking; Angelo Karaboyas; Ronald Pisoni; Friedrich Port; Bruce Robinson; Hugh Rayner Journal: Clin J Am Soc Nephrol Date: 2019-02-05 Impact factor: 8.237
Authors: Francesco Peyronel; Elisabetta Parenti; Paride Fenaroli; Giuseppe Daniele Benigno; Giovanni Maria Rossi; Umberto Maggiore; Enrico Fiaccadori Journal: BMJ Open Date: 2020-07-08 Impact factor: 2.692
Authors: Jennifer E Flythe; Matthew J Tugman; Julia H Narendra; Magdalene M Assimon; Quefeng Li; Yueting Wang; Steven M Brunelli; Alan L Hinderliter Journal: J Nephrol Date: 2020-09-25 Impact factor: 3.902